Evaluation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) mutagenicity using in vitro and in vivo Pig-a assays
Roberta A. Mittelstaedt(National Center for Toxicological Research), Robert H. Heflich(National Center for Toxicological Research), Page B. McKinzie(National Center for Toxicological Research), Seonggi Min(United States Food and Drug Administration), Javier R. Revollo(National Center for Toxicological Research), Hans Rosenfeldt(Virginia Commonwealth University), Yunan Tang(United States Food and Drug Administration), Dong-Jin Yang(Seoul National University Hospital), Azra Dad(National Center for Toxicological Research), Shu-Chieh Hu(United States Food and Drug Administration), Hyun-Ki Kang(National Center for Toxicological Research), Berran Yücesoy(United States Food and Drug Administration), Mason G. Pearce(National Center for Toxicological Research), Vasily N. Dobrovolsky(National Center for Toxicological Research), R Philip Yeager(Office of Science), Yiying Wang(National Center for Toxicological Research), Mallikarjuna S. Basavarajappa(National Center for Toxicological Research)
Mutation Research/Genetic Toxicology and Environmental Mutagenesis
October 29, 2018
Cited by 10
Related Papers
The NAD Biosynthesis Pathway Mediated by Nicotinamide Phosphoribosyltransferase Regulates Sir2 Activity in Mammalian Cells
|Journal of Biological Chemistry|2004|994
Nampt/PBEF/Visfatin Regulates Insulin Secretion in β Cells as a Systemic NAD Biosynthetic Enzyme
|Cell Metabolism|2007|899
The regulation of nicotinamide adenine dinucleotide biosynthesis by Nampt/PBEF/visfatin in mammals
|Current Opinion in Gastroenterology|2007|310
Structure of Nampt/PBEF/visfatin, a mammalian NAD+ biosynthetic enzyme
|Nature Structural & Molecular Biology|2006|295
Mechanisms Generating Diversity in Glucocorticoid Receptor Signaling
|Annals of the New York Academy of Sciences|2009|219